Related Experiment Video
Updated: Jan 6, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Pharmmaker: Pharmacophore modeling and hit identification based on druggability simulations
Ji Young Lee1, James M Krieger1, Hongchun Li1
1Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Pharmmaker integrates druggability simulations with pharmacophore modeling for drug discovery. This new tool streamlines virtual screening to identify potential drug candidates from compound libraries.
Area of Science:
- Computational chemistry
- Drug discovery
- Structural biology
Background:
- Druggability simulations characterize protein-drug binding.
- Pharmacophore models are crucial for virtual screening.
- A unified tool for simulation to screening is needed.
Purpose of the Study:
- To develop Pharmmaker, a novel computational tool.
- To integrate druggability simulations and pharmacophore modeling.
- To facilitate structure-based virtual screening for drug discovery.
Main Methods:
- Pharmmaker builds upon the ProDy application programming interface and DruGUI module.
- It involves identifying high-affinity residues and probe interactions.
- Top-ranked snapshots yield probe binding poses and protein conformations for pharmacophore model construction.
Main Results:
- Pharmmaker provides a systematic workflow from simulation to pharmacophore modeling.
- Pharmacophore models are generated using probe binding poses and protein conformations.
- These models serve as filters for identifying hits in virtual screening.
Conclusions:
- Pharmmaker addresses the lack of a comprehensive tool for drug discovery workflows.
- The tool enables efficient identification of potential drug candidates.
- Pharmmaker enhances computer-aided drug discovery by integrating multiple steps.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
08:49Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
Published on: June 20, 2025
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...